RE:ValuationThey are a growing company with more patients screened every month. They are in talk with countries all over the world. They also have a $5 million dollar contract(for a reason people on this board think it's $15 million, don't know why.) And hopefully good news regarding the pilot tests soon.
And they will get a IR team soon[1]
Hype about the hearth screening should bring this higher alone.
I am losing my patience but I will leave my shares to the PhD army that are making the software and not the CEO and managment.
[1] Stockhouse board member.